The saddest part is not the geopolitics—it is the people. When politics and the military repeatedly place national choices above ordinary citizens, a nation’s sovereignty can become the quiet subservience of its own people. (3/3)
As I had noted in an earlier post about Pakistan’s space missions receiving Chinese investment, the deeper China–US economic and strategic rivalry will have consequences far beyond trade. (1/3)
Pakistan may deepen its dependence on China, but I don’t believe it will lose its strategic space with the US. It may, in time, become a proxy arena for competing interests of both powers. (2/3)
Something subtly different about how X now renders in the browser. Perhaps an update, or a dynamically delivered package, or simply an illusion of perception- but the web experience feels remarkably close to the app. (1/2)
Since AI companies are destroying physical books to feed machines; the world is in a great turmoil.
The law may permit it. The First-Sale Doctrine generally allows an owner of a physical book to destroy it. But legality is not the same as wisdom.
Vande Mataram — is an emotion that awakens the soul of a nation.
In every note lies the courage of our freedom fighters, the love for our motherland, and the hope of a stronger, united India.
Vande Mataram! 🇮🇳
🇮🇳 Happy Independence Day!
Honouring the sacrifices that gave us our freedom.
Independence finds its true strength in justice, equality, values, & our commitment to the nation.
May India always rise with courage, unity, & dignity. 🇮🇳
#IndependenceDay#India
Pakistan’s Jinnah-1 mission is a welcome step in space exploration. Yet, with growing dependence on China, it also raises a strategic question: can Pakistan preserve meaningful autonomy while navigating intensifying US–China rivalry?
(1/2)
My previous blog distinguishes China’s patent landscape from the US. The US remains vital for advanced delivery systems, devices, algorithms, and pharma development, while WIPO/PCT reveals technologies seeking global protection.
China deserves separate attention for growing activity in molecular engineering, formulation, manufacturing, and intelligent delivery. My dataset covers 2020–2025, with a few historical records from 1912.
I analysed insulin patent technologies from 2020 to date—from long-acting & glucose-responsive insulin to smart delivery, closed-loop systems and AI. The journey goes back 120 years.